Su, Z <br/><br/>
The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease.  [electronic resource] 

 -  European journal of immunology  Mar 2001 
 - 947-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-2980 
<br/><br/><label>Standard No.: </label>10.1002/1521-4141(200103)31:3<947::aid-immu947>3.0.co;2-m  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Viral--immunology<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cell Line<br/>Cells, Cultured<br/>Cytotoxicity Tests, Immunologic<br/>Dendritic Cells--immunology<br/>Epstein-Barr Virus Infections--immunology<br/>Herpesvirus 4, Human--immunology<br/>Hodgkin Disease--immunology<br/>Humans<br/>Immunophenotyping<br/>Lymphocyte Activation<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Transfection<br/>Viral Matrix Proteins--genetics